Targeting Lyn regulates Snail family shuttling and inhibits metastasis

D Thaper1,2, S Vahid1,2, K M Nip1,2

  • 1Department of Urology, Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.

Oncogene
|March 14, 2017
PubMed

Insights

This study reveals Lyn kinase controls epithelial-mesenchymal transition (EMT) by regulating SNAI proteins. Targeting Lyn kinase reduces cancer metastasis and E-cadherin loss, offering a new therapeutic strategy for various cancers.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Epithelial-mesenchymal transition (EMT) is crucial for cancer metastasis.
  • EMT involves loss of cell adhesion and polarity, often mediated by SNAI transcription factors.
  • Understanding regulators of SNAI proteins is key to inhibiting metastasis.

Purpose of the Study:

  • To identify novel regulators of SNAI protein function in EMT.
  • To investigate the role of Lyn kinase in controlling SNAI protein localization and stability.
  • To evaluate Lyn kinase as a potential therapeutic target for reducing cancer metastasis.

Main Methods:

  • Investigated Lyn kinase's role in modulating SNAI protein localization and stability.
  • Utilized the Vav-Rac1-PAK1 pathway as a mechanistic link.
  • Assessed the effect of targeting Lyn kinase on EMT in vitro and metastasis in vivo.
  • Analyzed patient cancer samples to correlate Lyn expression with E-cadherin and metastatic status.

Main Results:

  • Lyn kinase was identified as a key modulator of SNAI family protein localization and stability.
  • Targeting Lyn kinase reduced EMT in vitro and primary tumor metastasis in vivo.
  • A negative correlation between Lyn and E-cadherin was observed across multiple cancer types.
  • High Lyn expression correlated with metastatic and metastasis-prone tumors.

Conclusions:

  • Lyn kinase plays a critical role in a novel, pancancer mechanism controlling EMT.
  • Lyn kinase regulates EMT via the Vav-Rac1-PAK1 pathway, impacting SNAI protein function.
  • Targeting Lyn kinase represents a promising strategy to inhibit cancer progression and metastasis.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.5K